Modern, intuitive, and reliable thermal cyclers excel at optimizing sequencing, cloning, and genotyping throughput. Choosing the right thermal cycler can be a daunting task. Among the considerations ...
CDSCO license on Form MD-5 authorizes CoSara to manufacture PCR Pro instrument in its Ranoli, India facility for sale or distribution SALT LAKE CITY, Feb. 5, 2026 /PRNewswire/ -- Co-Diagnostics, Inc. ...
Stilla Technologies, a leader in multiplex digital PCR technology, proudly announces the addition of two new digital PCR system configurations to the Nio™ product line, which debuted in November 2023 ...
Roche and Precision System Science, Co., Ltd (PSS) today announced the signing of an exclusive agreement to develop and manufacture a fully automated emulsion PCR instrument for Roche's portfolio of ...
Life Technologies Corporation has announced that its Applied Biosystems 7500 Fast Dx Real-Time PCR Instrument is available as a platform suitable for in vitro diagnostics (IVD) use in Europe. Clinical ...
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
Featuring a simple workflow with minimal hands-on time, the benchtop platform is disruptively priced at $30,000 -- enabling access to a broader community. The system is currently with early access ...
The Pharos V8 is a laser PCR (polymerase chain reaction) instrument powered by pulse-controlled amplification (PCA) technology. It features ultrafast nucleic acid amplification and microcyclers that ...
The leased facility will manufacture diagnostic instruments, equipment, and consumables.
The above button links to Coinbase. Yahoo Finance is not a broker-dealer or investment adviser and does not offer securities or cryptocurrencies for sale or facilitate trading. Coinbase pays us for ...
CDSCO license on Form MD-5 authorizes CoSara to manufacture PCR Pro instrument in its Ranoli, India facility for sale or distribution Mohal Sarabhai, CEO of CoSara, remarked, "We believe this landmark ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results